Capital Raising & Corporate Finance
IPOs: Offerings Keep Trickling In
Sticky inflation, interest rate hikes, and Russia’s ongoing war in Ukraine are among the factors that will continue to chill IPO prospects.
Author: Anthony Noto
Join the global community of corporate and public-sector finance industry leaders reading Global Finance monthly in print.
Click Here
News
Blackrock Bets On Bitcoin ETF
Until now, the SEC has only approved bitcoin-futures-based ETFs even though industry insiders contend they are riskier than bitcoin ETFs.
Capital Raising & Corporate Finance
PGA Tour Board Member Pleads with Colleagues: Reconsider Saudi Deal
Just as the US Senate prepares to talk golf on Capitol Hill, one PGA exec is urging his fellow directors to “evaluate alternative sources of capital.”
Capital Raising & Corporate Finance
Qatar’s Purchase Of Manchester United Stalls Due To Family Drama
Upheaval among the football club’s owners, and angry fans, puts a $6 billion-plus deal at stake.
Capital Raising & Corporate Finance
Nasdaq’s $10 Billion RegTech Deal Shows Urgency, Cost Of Compliance
Corporates are wielding M&A to scoop up the tech they need in order to keep up with strict rules and regulations.
Capital Raising & Corporate Finance
Saudi Arabia’s Middle America Makeover
Profit overrides principle with the recent PGA-LIV Golfdeal; expect more M&A in sports and other sectors.
Capital Raising & Corporate Finance
CFOs Draft New Game Plans
Finance chiefs are making tough calls and learning new lessons in a stressful economic and credit landscape. But layoffs aren’t the only option.
Capital Raising & Corporate Finance
Multinationals Get Squeezed By FX Volatility
North American industries most affected by currency exposure were professional services, biotech and pharmaceuticals, machinery, trading and distribution, chemicals and health equipment and supplies.
Capital Raising & Corporate Finance
Pharmaceutical Giant Sees Largest-Ever Bond Sale
Pfizer’s eight tranches of notes, priced from $3 billion to $6 billion each, will mature between 2025 and 2063.
Capital Raising & Corporate Finance
Pfizer’s $43B Pursuit Of Seagen: Q&A With Séverine Piot-Deval
Pfizer’s $31 billion bond sale to fund its $43 billion acquisition of cancer drug maker Seagen is one of the largest in history. Healthcare expert Severine Piot-Deval discusses the deal with Global Finance.
Capital Raising & Corporate Finance
Private Equity’s Dry Powder
PE firms are attempting to navigate a barren M&A landscape, with trillions in capital ready to deploy. But where?
Features
Finns Path To An IPO
VC support and debt financing fuel car-subscription services outside of Europe.